The global biopsy device market size accounted for USD 2,279 million in 2024 and is predicted to touch around USD 3,309 million by 2034, growing at a CAGR of 3.8% from 2024 to 2034.
The growing prevalence of cancers and the need for early detections are the key factors driving the growth of the biopsy device market. Technology developments are generating novel opportunities to improve growth of the market. The adoption of innovative technologies like imaging is significantly transforming the market. Moreover, government initiatives in the development of a well-established healthcare sector contribute to the market's success. Rising importance of preventive check-ups is surging in the market growth. The market is expected to transform due to increasing adoption of non-invasive procedures. Moreover, the surge in research and developments for novel innovative biopsy devices is likely to boost the market growth in the forecast period.
The biopsy device market is led by North America in 2023 due to increased prevalence of the cancer in the region. Countries like the United States and Canada are driving the regional market with increased developments and adoptions of the accurate and advanced cancer diagnostic equipment, including biopsy devices. The increased awareness of early detection of disease is expected to allow North America to continue dominating the market.
Published by Ajit Bansod
